GnRH III has been shown that it has lower endocrine effect in mammals than the human GnRH (GnRH-I, also called LH–RH), it binds to the GnRH receptors on cancer cells and exhibits anti-proliferative effect on many types of GnRH receptor-positive tumors. This evidence concerns the gene GNRH1 and cancer.